Реакция #44175

ord-331648d55fa94256b6a3643d83c4757a

Растворители

Условия реакции

Подробные условия
See reaction.notes.procedure_details.

Обработка

  1. 1
    Концентрированиеthen concentrated under vacuum
  2. 2
    Промывкаeluted with methanol
  3. 3
    КонцентрированиеThe combined basic fractions were concentrated under vacuum
  4. 4
    workup.DISSOLUTIONThe residue, (10 mg) was then dissolved in DCM (1 mL)
  5. 5
    workup.STIRRINGThe mixture was stirred for 1 h
  6. 6
    Концентрированиеthen concentrated under vacuum
  7. 7
    Другоеpurified by preparative mass-directed hplc

Методика

A solution of (R)-(1,1-dimethylethyl 2-{[(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)amino]methyl}-1-pyrrolidinecarboxylate in methanol was treated with a solution of hydrogen chloride in ether (1M). The resulting mixture was stirred 30 minutes then concentrated under vacuum and then loaded onto an ion-exchange cartridge (SCX-2) and eluted with methanol followed by ammonia in methanol (1 M). The combined basic fractions were concentrated under vacuum. The residue, (10 mg) was then dissolved in DCM (1 mL) and treated with triphosgene (23 mg, 0.3 eq.), diisopropylamine (4 uL, 3 eq.). The mixture was stirred for 1 h then concentrated under vacuum and purified by preparative mass-directed hplc to afford the title compound (3.1 mg).

Источник

DOI: 10.6084/m9.figshare.5104873.v1Патент: US07732600B2uspto-grants-2010_06